Adcock invests $40M in Johannesburg facility; Accellent selling plant to Perryman;

> Thirty-three cases of a rare fungal eye infection have been traced to Franck's Compounding Lab in Ocala, FL, where tests of products by the FDA found drugs contaminated by a variety of fungi and bacteria. Story

> Adcock Ingram of South Africa has opened a $38.3 million manufacturing facility in Johannesburg to make sterile drip bags, ampules and dialysis solutions for the sub-Saharan Africa market. Item

> Accellent, a contract manufacturer for the medical device industry, has agreed to sell a 68,000-square-foot manufacturing facility in Houston, PA, near Pittsburgh, to titanium producer The Perryman Company for an undisclosed sum. Release

> FDA orders Alexza Pharmaceuticals ($ALXA) to fix manufacturing issues, which the company says are device-related, before it will approve its NDA for Adasuve, a schizophrenic and bipolar disorder treatment. Story

 

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.